WEST PALM BEACH, Fla. – Sept. 2, 2026 – Global law firm Greenberg Traurig, P.A. represented JATT III Acquisition Corp (the Company) in the closing of its initial public offering of 6.9 million ordinary shares at a price of $10 per share Aug. 27, including the underwriter’s full exercise of its overallotment option to purchase an additional 900,000 ordinary shares. Total gross proceeds from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses. The shares began trading on the Nasdaq Capital Market under the ticker symbol “JTTT” Aug. 26.
AI Biotechnology LLC, an affiliate of Access Industries, Inc. and Vianti Capital Fund I, L.P. have indicated non-binding interests to participate in a private placement that may occur concurrently with the consummation of the Company’s initial business combination.
The offering included participation from Adage Capital Partners, L.P., ADAR1 Capital, Affinity Asset Advisors, LLC, Columbia Threadneedle Investments, Deep Track Capital, Great Point Partners, LLC, Janus Henderson Investors, Nantahala Capital, RA Capital Management, Sirenia Capital Management LP, Squadron Capital Management LLC, and other institutional investors.
The Greenberg Traurig team was led by Vice Chair Alan I. Annex in Miami, Corporate Practice Shareholders Tricia Branker in West Palm Beach and Adam S. Namoury in New York, and Associate Tiange “Tim” Chen in New York, with support from Law Clerk/JD Jung Baek in Washington, D.C.